Despite policies that try to drive prices down by giving consumers information, price transparency in healthcare does not work, the report says.
Category: Healthcare Finance News
Healthcare execs say telehealth is their No. 1 pandemic tech problem
Other major challenges include remote patient monitoring, interoperability, real-time data analytics, work-from-home resources and patient surveillance, according to a new KLAS report.
Home healthcare spending down almost a quarter under PDGM
Providers haven’t been responding to Low Utilization Payment Adjustment thresholds as expected, the analysis finds.
Digital health adoption stalled prior to the COVID-19 pandemic, but recent momentum signals change
While barriers remain, the forced use of digital health services during the health crisis leaves an opportunity for provider adoption.
CMS proposes rule on pathway to Medicare coverage for innovative technology
The proposed rule has been commended by the Advanced Medical Technology Association for getting innovative technology to patients that need them.
Out-of-network providers charge significantly more than the commercial price for COVID-19 tests
In response to what AHIP said was price gouging, the organization has called for policy changes to stop the practice from continuing.
Prior health insurance coverage disruptions linked to issues with healthcare access for cancer patients
About 260,000 currently insured cancer survivors ages 18-64 had coverage disruptions in 2018.
CMS’ requirement of a positive COVID-19 test for 20% bonus may be burdensome for hospitals
Failing to initially show a positive test result for a coronavirus patient could lead to appeals and administrative headaches.
Hospital revenue at risk in CMS’s proposal to move joint replacement to outpatient care
At stake is $3.2 billion in revenue for a one-day length of stay as 80% of revenue for all services is in joint replacement.
Operation Warp Speed clinical trials have robust participation from diverse subjects, officials say
The project expects two more trials to enter phase three by mid-September, with results from the first trials expected between October and December.
